PTIX

Protagenic Therapeutics, Inc. - Common Stock (PTIX)

About Protagenic Therapeutics, Inc. - Common Stock (PTIX)

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Details

Daily high

$1.56

Daily low

$1.48

Price at open

$1.55

52 Week High

$7.16

52 Week Low

$1.18

Market cap

3.0M

Dividend yield

0.00%

Volume

43,491

Avg. volume

113,977

P/E ratio

-.22

Protagenic Therapeutics, Inc. - Common Stock News